Tdspharm Co., Ltd.
Research Tdspharm Co., Ltd. (464280.KQ) on Bullrun: market cap KRW 26.15B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker464280.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyKRW
- Market capKRW 26.15B
- Financial periodQ2 2026
- RevenueKRW 8.08B
- Net incomeKRW 959.03M
- Free cash flowKRW 1.49B
- Gross margin23.6%
Valuation Snapshot
latest market cap is KRW 26.15B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 26.15B | n/a | n/a | n/a |
Dividend history
About Tdspharm Co., Ltd.
Tdspharm Co., Ltd. researches, develops, and produces pharmaceuticals and cosmetics in South Korea and internationally. It offers general medicines, prescription drugs, and non-medicinal products. The company was founded in 2002 and is based in Seongnam-si, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Tdspharm Co., Ltd.'s market cap?
Tdspharm Co., Ltd.'s market capitalization is KRW 26.15B.
What does Tdspharm Co., Ltd. do?
Tdspharm Co., Ltd. researches, develops, and produces pharmaceuticals and cosmetics in South Korea and internationally. It offers general medicines, prescription drugs, and non-medicinal products. The company was founded in 2002 and is based in Seongnam-si, South Korea.